Teva Pharmaceutical beats by $0.13, misses on revenue

|About: Teva Pharmaceutical Indust... (TEVA)|By:, SA News Editor

Teva Pharmaceutical (NYSE:TEVA): Q3 Non-GAAP EPS of $0.68 beats by $0.13; GAAP EPS of -$0.27 misses by $0.37.

Revenue of $4.53B (-19.4% Y/Y) misses by $20M.

Shares +1.15% PM.

Press Release

Subscribe for full text news in your inbox